BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28587923)

  • 1. Generation and Validation of Intracellular Ubiquitin Variant Inhibitors for USP7 and USP10.
    Zhang W; Sartori MA; Makhnevych T; Federowicz KE; Dong X; Liu L; Nim S; Dong A; Yang J; Li Y; Haddad D; Ernst A; Heerding D; Tong Y; Moffat J; Sidhu SS
    J Mol Biol; 2017 Nov; 429(22):3546-3560. PubMed ID: 28587923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-specific protease 7 (USP7): an emerging drug target for cancer treatment.
    Carreira LD; Oliveira RI; Moreira VM; Salvador JAR
    Expert Opin Ther Targets; 2023; 27(11):1043-1058. PubMed ID: 37789645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of potent small molecule ubiquitin-specific protease 10 inhibitors with anti-hepatocellular carcinoma activity through regulating YAP expression.
    Lu Y; Gao J; Wang P; Chen H; He X; Luo M; Guo Y; Li L; Zhuang W; Zhang B; Lin N; Li J; Zhou Y; Dong X; Che J
    Eur J Med Chem; 2024 Jun; 272():116468. PubMed ID: 38718626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP7 as an emerging therapeutic target: A key regulator of protein homeostasis.
    Guo NJ; Wang B; Zhang Y; Kang HQ; Nie HQ; Feng MK; Zhang XY; Zhao LJ; Wang N; Liu HM; Zheng YC; Li W; Gao Y
    Int J Biol Macromol; 2024 Apr; 263(Pt 1):130309. PubMed ID: 38382779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of YCH2823 as a novel USP7 inhibitor for cancer therapy.
    Cheng YJ; Zhuang Z; Miao YL; Song SS; Bao XB; Yang CH; He JX
    Biochem Pharmacol; 2024 Apr; 222():116071. PubMed ID: 38387527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ubiquitin E3 ligase MARCH7 is differentially regulated by the deubiquitylating enzymes USP7 and USP9X.
    Nathan JA; Sengupta S; Wood SA; Admon A; Markson G; Sanderson C; Lehner PJ
    Traffic; 2008 Jul; 9(7):1130-45. PubMed ID: 18410486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF.
    Jurisic A; Sung PJ; Wappett M; Daubriac J; Lobb IT; Kung WW; Crawford N; Page N; Cassidy E; Feutren-Burton S; Rountree JSS; Helm MD; O'Dowd CR; Kennedy RD; Gavory G; Cranston AN; Longley DB; Jacq X; Harrison T
    Clin Transl Med; 2024 Apr; 14(4):e1648. PubMed ID: 38602256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 2.2 Å resolution structure of the USP7 catalytic domain in a new space group elaborates upon structural rearrangements resulting from ubiquitin binding.
    Molland K; Zhou Q; Mesecar AD
    Acta Crystallogr F Struct Biol Commun; 2014 Mar; 70(Pt 3):283-7. PubMed ID: 24598911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deubiquitinases in hematological malignancies.
    Lei H; Wang J; Hu J; Zhu Q; Wu Y
    Biomark Res; 2021 Aug; 9(1):66. PubMed ID: 34454635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-specific protease 7 inhibitors reveal a differentiated mechanism of p53-driven anti-cancer activity.
    Futran AS; Lu T; Amberg-Johnson K; Xu J; Yang X; He S; Boyce S; Bell JA; Pelletier R; Suzuki T; Huang X; Qian H; Fang L; Xing L; Xu Z; Kurtz SE; Tyner JW; Tang W; Guo T; Akinsanya K; Madge D; Jensen KK
    iScience; 2024 May; 27(5):109693. PubMed ID: 38689642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 upregulation by USP7-engaging molecular glues.
    Li Z; Wang Z; Zhong C; Zhang H; Liu R; An P; Ma Z; Lu J; Pan C; Zhang Z; Cao Z; Hu J; Xing D; Fei Y; Ding Y; Lu B
    Sci Bull (Beijing); 2024 Apr; ():. PubMed ID: 38734583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The USP7 protein interaction network and its roles in tumorigenesis.
    Al-Eidan A; Wang Y; Skipp P; Ewing RM
    Genes Dis; 2022 Jan; 9(1):41-50. PubMed ID: 35005106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and Characterization of Engineered Ubiquitin Variants to Modulate the Ubiquitin Signaling Cascade.
    Liang CT; Roscow O; Zhang W
    Cold Spring Harb Protoc; 2024 Apr; 2024(4):107784. PubMed ID: 36997275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of the USP10-HDAC6 axis in lung cancer - A path to precision medicine.
    Zhang XM; Gavande N; Parajuli P; Bepler G
    J Cancer Biol; 2021; 2(1):. PubMed ID: 34746935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging role of deubiquitylating enzyme USP21 as a potential therapeutic target in cancer.
    Shi ZY; Li CY; Chen RY; Shi JJ; Liu YJ; Lu JF; Yang GJ; Chen J
    Bioorg Chem; 2024 Jun; 147():107400. PubMed ID: 38688196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of deubiquitination in breast cancer.
    Kong L; Jin X
    Gene; 2024 Apr; 902():148175. PubMed ID: 38242375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of USP7 inhibition by selective small-molecule inhibitors.
    Turnbull AP; Ioannidis S; Krajewski WW; Pinto-Fernandez A; Heride C; Martin ACL; Tonkin LM; Townsend EC; Buker SM; Lancia DR; Caravella JA; Toms AV; Charlton TM; Lahdenranta J; Wilker E; Follows BC; Evans NJ; Stead L; Alli C; Zarayskiy VV; Talbot AC; Buckmelter AJ; Wang M; McKinnon CL; Saab F; McGouran JF; Century H; Gersch M; Pittman MS; Marshall CG; Raynham TM; Simcox M; Stewart LMD; McLoughlin SB; Escobedo JA; Bair KW; Dinsmore CJ; Hammonds TR; Kim S; Urbé S; Clague MJ; Kessler BM; Komander D
    Nature; 2017 Oct; 550(7677):481-486. PubMed ID: 29045389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP7 small-molecule inhibitors interfere with ubiquitin binding.
    Kategaya L; Di Lello P; Rougé L; Pastor R; Clark KR; Drummond J; Kleinheinz T; Lin E; Upton JP; Prakash S; Heideker J; McCleland M; Ritorto MS; Alessi DR; Trost M; Bainbridge TW; Kwok MCM; Ma TP; Stiffler Z; Brasher B; Tang Y; Jaishankar P; Hearn BR; Renslo AR; Arkin MR; Cohen F; Yu K; Peale F; Gnad F; Chang MT; Klijn C; Blackwood E; Martin SE; Forrest WF; Ernst JA; Ndubaku C; Wang X; Beresini MH; Tsui V; Schwerdtfeger C; Blake RA; Murray J; Maurer T; Wertz IE
    Nature; 2017 Oct; 550(7677):534-538. PubMed ID: 29045385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7.
    Lamberto I; Liu X; Seo HS; Schauer NJ; Iacob RE; Hu W; Das D; Mikhailova T; Weisberg EL; Engen JR; Anderson KC; Chauhan D; Dhe-Paganon S; Buhrlage SJ
    Cell Chem Biol; 2017 Dec; 24(12):1490-1500.e11. PubMed ID: 29056421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of USP7: A High Incidence of E3 Complexes.
    Kim RQ; Sixma TK
    J Mol Biol; 2017 Nov; 429(22):3395-3408. PubMed ID: 28591556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.